Business Context and Reporting Period
This Form 8-K Current Report was filed by SRx Health Solutions, Inc. on July 14, 2025, covering events that occurred on July 8, 2025, and July 14, 2025. The filing primarily addresses significant changes in executive leadership and the execution of new employment agreements.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation structures and employment terms.
Material Changes
- CEO Transition: Adesh Vora voluntarily resigned as Chief Executive Officer on July 8, 2025. The resignation was not due to any dispute regarding financial statements, internal controls, or operations. Mr. Vora was appointed Vice Chairman of the Board.
- New CEO Appointment: Kent Cunningham was appointed Chief Executive Officer effective July 8, 2025.
- CFO Compensation Adjustment: Carolina Martinez, Chief Financial Officer, received an amendment to her employment agreement increasing her annual base salary to $325,000 (retroactive to June 19, 2025) and a one-time bonus of $150,000.
Guidance, Outlook, and Management Commentary
While no formal financial guidance is provided, the new CEO's employment agreement includes specific performance-based incentives that signal management's focus on profitability:
- CEO Equity Incentive: Kent Cunningham is eligible for a one-time equity award of Common Stock valued at $3,000,000, contingent upon the Company achieving net profitability for three (3) consecutive fiscal quarters.
- CEO Bonus Structure: Mr. Cunningham is eligible for an annual performance bonus of 70% of his base salary ($444,000), with 50% of the 2025 bonus tied to specific objectives.
- Severance Provisions: The agreement outlines severance of 12 months' base salary for termination without Cause or for Good Reason, and 24 months' base salary plus 40% of the pro-rata bonus in the event of a Change in Control.
- CFO Clawback: Ms. Martinez's $150,000 bonus is subject to a clawback provision if she is terminated for Cause or resigns without Good Reason within 90 days of the amendment.
Investor Verification Checklist
- Verify the Company's current financial status to assess the feasibility of achieving the "three consecutive quarters of net profitability" required for the CEO's $3 million equity award.
- Review the full text of Exhibit 10.1 (Kent Cunningham Executive Employment Agreement) for detailed definitions of "Cause," "Good Reason," and "Change in Control."
- Confirm the impact of the new executive compensation structure on future cash flow and equity dilution.
- Monitor the transition period to ensure operational stability following the CEO change.